You have 9 free searches left this month | for more free features.

linagliptin

Showing 26 - 50 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
  • Diabetes Mellitus, Type 2
  • linagliptin
  • +3 more
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Diabetic Nephropathy Type 2 Trial in Gentofte (Linagliptin, Empagliflozin, Telmisartan)

Withdrawn
  • Diabetic Nephropathy Type 2
  • Linagliptin
  • +3 more
  • Gentofte, Denmark
    Steno Diabetes Center Copenhagen
Sep 12, 2018

Type 2-diabetes Trial in Erlangen, Nuremberg (Linagliptin, Placebo)

Completed
  • Type 2-diabetes
  • Linagliptin
  • Placebo
  • Erlangen, Germany
  • +1 more
Jan 11, 2018

Type2 Diabetes Trial in Seoul (evogliptin, Linagliptin)

Completed
  • Type2 Diabetes
  • Seoul, Korea, Republic of
    Division of Endocrinology and Metabolism, Department of Internal
Jul 19, 2018

Healthy Trial in Biberach (Empagliflozin, Linagliptin)

Completed
  • Healthy
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Jun 27, 2017

Type 2 Diabetes Trial in Prague (Exenatide, Linagliptin, Gliclazide)

Completed
  • Type 2 Diabetes Mellitus
  • Prague, Czechia
    General University Hospital
Feb 6, 2018

SGLT-2 Inhibitors, Advanced Glycation End Products, Diabetes Trial (empagliflozin, linagliptin)

Withdrawn
  • SGLT-2 Inhibitors
  • +2 more
  • (no location specified)
Feb 13, 2018

Type 2 Diabetes, Peritoneal Dialysis Trial in Guangzhou (Linagliptin, Humalog Mix 75/25)

Unknown status
  • Type 2 Diabetes Mellitus
  • Peritoneal Dialysis
  • Linagliptin
  • Humalog Mix 75/25
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Oct 20, 2017

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Placebo
  • Linagliptin
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Type 2 Trial in Worldwide (Glimepiride, Metformin, Pioglitazone)

Terminated
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +33 more
Sep 25, 2019

Diabetes, Type 2 Trial in Seoul (Mosapride citrate, Linagliptin, Acetaminophen (paracetamol))

Completed
  • Diabetes Mellitus, Type 2
  • Mosapride citrate
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 27, 2017

Diabetes, Type 2 Trial in Worldwide (, linagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • placebo
  • linagliptin
  • Sheffield, Alabama
  • +144 more
Jun 1, 2018

Diabetes Type 2 (T2DM), Vascular Inflammation, Plaque Morphology Trial in Aachen, Maastricht (Linagliptin, Placebo)

Terminated
  • Diabetes Mellitus Type 2 (T2DM)
  • +2 more
  • Linagliptin
  • Placebo
  • Aachen, Germany
  • +1 more
Apr 10, 2017

Diabetes Trial in Neuss (Linagliptin)

Completed
  • Diabetes Mellitus
  • Linagliptin
  • Neuss, NRW, Germany
    Profil Institut für Stoffwechselforschung GmbH
Mar 1, 2017

Diabetes Type 2 (T2DM), Left Ventricular Diastolic Dysfunction Trial in Aachen (Linagliptin, )

Terminated
  • Diabetes Mellitus Type 2 (T2DM)
  • Left Ventricular Diastolic Dysfunction
  • Linagliptin
  • placebo
  • Aachen, Germany
    Department of Internal Medicine I, University Hospital
Apr 10, 2017

Type II Diabetes Trial in Boston (Linagliptin, Placebo, Microcirculation testing)

Completed
  • Type II Diabetes Mellitus
  • Linagliptin
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 17, 2016

Ascertainment of EMR-based Clinical Covariates Among Patients

Completed
  • Diabetes Mellitus, Type 2
  • linagliptin
  • Boston, Massachusetts
    Boehringer Ingelheim Investigational Site
Dec 15, 2016

Healthy Trial in Biberach (Linagliptin, Metformin, Linagliptin/Metformin FDC)

Completed
  • Healthy
  • Linagliptin
  • +2 more
  • Biberach, Germany
    1288.11.1 Boehringer Ingelheim Investigational Site
Jun 23, 2016

Healthy Trial in Ingelheim (Linagliptin, Linagliptin/Metformin ER FDC, Metformin ER)

Completed
  • Healthy
  • Linagliptin
  • +2 more
  • Ingelheim, Germany
    1288.10.1 Boehringer Ingelheim Investigational Site
Jun 23, 2016

Healthy Trial in Biberach (Linagliptin/Metformin ER FDC, Linagliptin, Metformin ER)

Completed
  • Healthy
  • Linagliptin/Metformin ER FDC
  • +2 more
  • Biberach, Germany
    1288.9.1 Boehringer Ingelheim Investigational Site
Jun 23, 2016

Type 2 Diabetes Trial in Groningen (Linagliptin, )

Completed
  • Type 2 Diabetes Mellitus
  • Linagliptin
  • placebo
  • Groningen, Netherlands
    University Medical Center Groningen
May 17, 2016

Diabetes, Type 2 Trial in China, Malaysia, Philippines (Placebo, Linagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Placebo
  • Linagliptin
  • Beijing, China
  • +18 more
Jul 25, 2016

Diabetes, Type 2 Trial in China, Malaysia, Philippines (Linagliptin, )

Completed
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • placebo
  • Beijing, China
  • +18 more
Jul 25, 2016

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin + Linagliptin, Empaglifozin + Linagliptin )

Completed
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • +2 more
  • Gulf Shores, Alabama
  • +89 more
Jun 9, 2016

Type 1 Diabetes Trial in Chandigarh (Linagliptin, Placebo)

Unknown status
  • Type 1 Diabetes Mellitus
  • Linagliptin
  • Placebo
  • Chandigarh, India
    Department of Endocrinology, PGIMER
Mar 31, 2016